JP2023524911A5 - - Google Patents
Info
- Publication number
- JP2023524911A5 JP2023524911A5 JP2023509461A JP2023509461A JP2023524911A5 JP 2023524911 A5 JP2023524911 A5 JP 2023524911A5 JP 2023509461 A JP2023509461 A JP 2023509461A JP 2023509461 A JP2023509461 A JP 2023509461A JP 2023524911 A5 JP2023524911 A5 JP 2023524911A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- peptide
- fusion inhibitor
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063015479P | 2020-04-24 | 2020-04-24 | |
| US63/015,479 | 2020-04-24 | ||
| PCT/US2021/028667 WO2021216891A2 (en) | 2020-04-24 | 2021-04-22 | Lipid-peptide fusion inhibitors as sars-cov-2 antivirals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023524911A JP2023524911A (ja) | 2023-06-13 |
| JP2023524911A5 true JP2023524911A5 (https=) | 2024-05-07 |
Family
ID=78270019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023509461A Pending JP2023524911A (ja) | 2020-04-24 | 2021-04-22 | Ｓａｒｓ－ｃｏｖ－２抗ウイルス薬としての脂質－ペプチド融合物阻害剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230159597A1 (https=) |
| EP (1) | EP4139330A4 (https=) |
| JP (1) | JP2023524911A (https=) |
| KR (1) | KR20230028719A (https=) |
| CN (1) | CN115916806A (https=) |
| BR (1) | BR112022021528A2 (https=) |
| CA (1) | CA3175831A1 (https=) |
| IL (1) | IL297498A (https=) |
| WO (1) | WO2021216891A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118354791A (zh) | 2021-10-22 | 2024-07-16 | 威斯康星校友研究基金会 | 抑制导致新冠肺炎疾病的病毒sars-cov-2感染的肽 |
| WO2024016011A2 (en) * | 2022-07-15 | 2024-01-18 | The Trustees Of Columbia University In The City Of New York | Broad spectrum inhibition of human coronaviruses by lipopeptides derived from the c-terminal heptad repeat of betacoronaviruses |
| WO2025231157A2 (en) * | 2024-04-30 | 2025-11-06 | Decoy Therapeutics Inc. | New anti-viral therapeutic peptides, conjugates, and methods of use thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007526213A (ja) * | 2003-04-28 | 2007-09-13 | セコイア、ファーマシューティカルズ、インコーポレイテッド | コロナウイルスによる感染症の治療、管理および予防用の抗ウイルス剤 |
| WO2005077103A2 (en) * | 2004-02-12 | 2005-08-25 | Regents Of The University Of Colorado | Compositions and methods for modification and prevention of sars coronavirus infectivity |
| GB0720503D0 (en) * | 2007-10-22 | 2007-11-28 | Angeletti P Ist Richerche Bio | New compound |
| WO2010089129A1 (en) * | 2009-02-06 | 2010-08-12 | Cormus Srl | Inhibitors of viral fusion and uses thereof |
| EP2603241A2 (en) * | 2010-08-11 | 2013-06-19 | Jv Bio Srl | Multimeric inhibitors of viral fusion and uses thereof |
| CN104151403B (zh) * | 2013-04-08 | 2020-11-03 | 中国医学科学院药物研究所 | 一类多肽或其衍生物、及其在流感病毒感染中的应用 |
| WO2015171924A2 (en) * | 2014-05-07 | 2015-11-12 | Cornell University | Inhibitors of fusion between viral and cell membranes as well as compositions and methods of using them |
| WO2017015457A1 (en) * | 2015-07-21 | 2017-01-26 | Modernatx, Inc. | Ebola vaccine |
| US20180243225A1 (en) * | 2017-01-25 | 2018-08-30 | Modernatx, Inc. | Ebola/marburg vaccines |
| WO2021178714A2 (en) * | 2020-03-04 | 2021-09-10 | Dana-Farber Cancer Institute, Inc. | ANTIVIRAL STRUCTURALLY-STABILIZED SARS-CoV-2 PEPTIDES AND USES THEREOF |
-
2021
- 2021-04-22 IL IL297498A patent/IL297498A/en unknown
- 2021-04-22 WO PCT/US2021/028667 patent/WO2021216891A2/en not_active Ceased
- 2021-04-22 EP EP21792967.8A patent/EP4139330A4/en active Pending
- 2021-04-22 US US17/996,917 patent/US20230159597A1/en active Pending
- 2021-04-22 CA CA3175831A patent/CA3175831A1/en active Pending
- 2021-04-22 BR BR112022021528A patent/BR112022021528A2/pt unknown
- 2021-04-22 JP JP2023509461A patent/JP2023524911A/ja active Pending
- 2021-04-22 KR KR1020227041142A patent/KR20230028719A/ko active Pending
- 2021-04-22 CN CN202180044021.1A patent/CN115916806A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023524911A5 (https=) | ||
| Zhirnov et al. | Aprotinin and similar protease inhibitors as drugs against influenza | |
| RU2524304C2 (ru) | Применение соли ацетилсалициловой кислоты для лечения вирусных инфекций | |
| JPH09502424A (ja) | 安定化製薬性ペプチド組成 | |
| JP2009102370A (ja) | グリシルリジン酸及び抗ウイルス活性を有する蛋白質を少なくとも一つ含む、抗ウイルス薬剤組成物 | |
| WO2022081711A4 (en) | Lipopeptide fusion inhibitors as sars-cov-2 antivirals | |
| JP2024504225A5 (https=) | ||
| US20240398893A1 (en) | Anti-coronavirus polypeptide as well as derivative and application thereof | |
| CA2817787C (en) | Composition comprising a peptide and an inhibitor of viral neuraminidase | |
| WO2023232095A9 (zh) | 一种基于病毒阻断剂的口腔喷雾制剂及其用途 | |
| JP2023527791A (ja) | ウイルス性呼吸器感染症を治療するための方法 | |
| CN114870061B (zh) | 一种基于病毒阻断剂的空气喷雾剂及其用途 | |
| WO2021207848A1 (en) | Mers-cov vaccine | |
| Gao et al. | Antiviral peptides with in vivo activity: development and modes of action | |
| JPH06507386A (ja) | 治療用ペプチド | |
| EP1797112B1 (en) | Inhibitors of hepatitits c virus | |
| US20240115667A1 (en) | Diphenhydramine and lactoferrin for prevention and treatment of covid-19 | |
| US20100311656A1 (en) | Treatment or prevention of respiratory viral infections with alpha thymosin peptides | |
| US20240261392A1 (en) | Compositions and methods to increase coronavirus immune response | |
| CN120813372A (zh) | 针对冠状病毒的疫苗 | |
| WO2022135622A3 (es) | Péptidos para el tratamiento de infecciones respiratorias de origen viral | |
| WO2021003365A1 (en) | Compositions and methods useful for ebola virus infection | |
| WO1999034777A1 (en) | Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus | |
| WO2024096742A1 (en) | SARS-CoV-2 BINDING POLYPEPTIDE | |
| EP4612174A1 (en) | Sars-cov-2 binding antibody |